AUPH — Aurinia Pharmaceuticals Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Aurinia Pharmaceuticals Inc (AUPH), worth $30.65M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $26.27M | 0.04% | -7% |
| Navellier | $4.36M | 0.35% | +123.7% |
| Persistent | $16.39K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.